Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
LFSCvsARKGETF Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. LFSC's top 3 sector exposures are Health Care and Sovereign. In contrast, ARKG's top sector exposures are Health Care and Information Technology. LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.75% for ARKG. LFSC is down -3.7% year-to-date (YTD) with +$7M in YTD flows. ARKG performs better with -1.38% YTD performance, and -$16M in YTD flows. Run a side-by-side ETF comparison of LFSC and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LFSC vs ARKG performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC ARKG | -2.09%-1.00% | -10.37%-6.62% | -3.70%-1.38% | +60.97%+31.18% | n/a+0.39% | n/a-67.04% |
| Flows | LFSC ARKG | +$7M-$82M | +$8M-$67M | +$7M-$16M | +$18M-$207M | --$614M | --$2.74B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC ARKG | +22.01%+38.80% | +28.67%+44.65% | n/a+42.34% | n/a+45.24% |
| Max drawdown | LFSC ARKG | -13.02%-19.50% | -19.03%-23.94% | n/a-51.98% | n/a-80.33% |
| Max drawdown duration | LFSC ARKG | 90d46d | 70d77d | n/a964d | n/a1820d |
LFSC | ARKG | |
Last sale 3/11/2026 at 1:30 PM | $34.80 | $27.67 |
| Previous close 03/10/2026 | $35.21 | $27.93 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
LFSC | ARKG | |
|---|---|---|
| Last price | $34.80 | $27.67 |
| 1D performance | -1.17% | -0.93% |
| AuM | $95.79 M | $1.14 B |
| E/R | 0.79% | 0.75% |
LFSC | ARKG | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Emerald Group | Ark Investment |
| Benchmark | - | - |
| N° of holdings | 34 | 30 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | April 2, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the LFSC and ARKG ETFs performed in 2026?
As of March 10, 2026, LFSC is down -3.7% year-to-date (YTD), while ARKG has lost -1.38%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: LFSC or ARKG?
Year-to-date, the LFSC ETF saw +$7M in flows, compared to -$16M for ARKG.
Which ETF is more volatile: LFSC or ARKG?
Over the past year, LFSC had a volatility of 28.67%, while ARKG experienced 44.65%.
Which ETF is bigger: LFSC or ARKG?
As of March 10, 2026, LFSC holds $95.79 M in assets under management (AUM), while ARKG manages $1.14 B.
What sectors do the LFSC and ARKG ETFs invest in?
LFSC leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.
What are the top holdings of the LFSC ETF and ARKG ETF?
LFSC top holdings include COGENT BIOSCIENCES, LIVANOVA and GUARDANT HEALTH INC. ARKG holds in its top three: CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC.
Which ETF is more diversified: LFSC or ARKG?
LFSC holds 42 securities with 68.94% of its assets in the top 15. ARKG has 30 securities and a top 15 weight of 63.79%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
